Purnell B, Petrucci A, Li R, Buchanan G
Epilepsia. 2024; 65(9):2812-2826.
PMID: 38980980
PMC: 11534534.
DOI: 10.1111/epi.18059.
Nikodijevic O, Jacobson K, Daly J
Drug Dev Res. 2024; 30(2):104-110.
PMID: 38250653
PMC: 10798035.
DOI: 10.1002/ddr.430300209.
Romero-Martinez B, Montano L, Solis-Chagoyan H, Sommer B, Ramirez-Salinas G, Perez-Figueroa G
Int J Mol Sci. 2021; 22(11).
PMID: 34067243
PMC: 8196824.
DOI: 10.3390/ijms22115460.
Boularan C, Gales C
Front Pharmacol. 2015; 6:203.
PMID: 26483685
PMC: 4589651.
DOI: 10.3389/fphar.2015.00203.
Fredholm B, Jacobson K
Heterocycles. 2015; 79(1):73-83.
PMID: 26113768
PMC: 4477965.
DOI: 10.3987/COM-08-S(D)Memoire-2.
Adenosine A1 and A2A receptors are not upstream of caffeine's dopamine D2 receptor-dependent aversive effects and dopamine-independent rewarding effects.
Sturgess J, Ting-A-Kee R, Podbielski D, Sellings L, Chen J, van der Kooy D
Eur J Neurosci. 2010; 32(1):143-54.
PMID: 20576036
PMC: 2994015.
DOI: 10.1111/j.1460-9568.2010.07247.x.
Transformation products of extracellular NAD(+) in the rat liver: kinetics of formation and metabolic action.
Broetto-Biazon A, Bracht F, de Sa-Nakanishi A, Lopez C, Constantin J, Kelmer-Bracht A
Mol Cell Biochem. 2007; 307(1-2):41-50.
PMID: 17846864
DOI: 10.1007/s11010-007-9582-7.
Structure-activity relationships at human and rat A2B adenosine receptors of xanthine derivatives substituted at the 1-, 3-, 7-, and 8-positions.
Kim S, Marshall M, Melman N, Kim H, Muller C, Linden J
J Med Chem. 2002; 45(11):2131-8.
PMID: 12014951
PMC: 6927247.
DOI: 10.1021/jm0104318.
An adenosine A3 receptor-selective agonist does not modulate calcium-activated potassium currents in hippocampal CA1 pyramidal neurons.
Dunwiddie T, Jacobson K, Diao L
Prog Brain Res. 1999; 120:275-85.
PMID: 10551004
PMC: 3449169.
DOI: 10.1016/s0079-6123(08)63562-1.
Possible mechanism of interaction of GABAergic-adenosinergic systems in the regulation of theophylline-induced locomotor activity under its nontolerant and tolerant conditions.
Mandal M, Poddar M
Neurochem Res. 1999; 24(6):757-65.
PMID: 10447459
DOI: 10.1023/a:1020731629961.
Characterization and tissue location of the neural adenosine receptor in the rat ileum.
Coupar I
Br J Pharmacol. 1999; 126(5):1269-75.
PMID: 10205018
PMC: 1565885.
DOI: 10.1038/sj.bjp.0702411.
Spinal cord adenosine receptor stimulation in rats inhibits peripheral neutrophil accumulation. The role of N-methyl-D-aspartate receptors.
Bong G, Rosengren S, Firestein G
J Clin Invest. 1996; 98(12):2779-85.
PMID: 8981924
PMC: 507743.
DOI: 10.1172/JCI119104.
Preferential activation of excitatory adenosine receptors at rat hippocampal and neuromuscular synapses by adenosine formed from released adenine nucleotides.
Cunha R, Correia-de-Sa P, Sebastiao A, Ribeiro J
Br J Pharmacol. 1996; 119(2):253-60.
PMID: 8886406
PMC: 1915871.
DOI: 10.1111/j.1476-5381.1996.tb15979.x.
8-(3-Chlorostyryl)caffeine (CSC) is a selective A2-adenosine antagonist in vitro and in vivo.
Jacobson K, Nikodijevic O, Padgett W, Maillard M, Daly J
FEBS Lett. 1993; 323(1-2):141-4.
PMID: 8495727
PMC: 3468328.
DOI: 10.1016/0014-5793(93)81466-d.
Characterization of the adenosine receptors of the rat superior cervical ganglion.
Connolly G, Stone T, Brown F
Br J Pharmacol. 1993; 110(2):854-60.
PMID: 8242261
PMC: 2175924.
DOI: 10.1111/j.1476-5381.1993.tb13891.x.
A comparison of A2 adenosine receptor-induced cyclic AMP generation in cerebral cortex and relaxation of pre-contracted aorta.
Alexander S, Losinski A, Kendall D, Hill S
Br J Pharmacol. 1994; 111(1):185-90.
PMID: 8012695
PMC: 1910056.
DOI: 10.1111/j.1476-5381.1994.tb14042.x.
Caffeine-induced locomotor activity: possible involvement of GABAergic-dopaminergic-adenosinergic interaction.
Mukhopadhyay S, Poddar M
Neurochem Res. 1995; 20(1):39-44.
PMID: 7739757
DOI: 10.1007/BF00995150.
Species differences in structure-activity relationships of adenosine agonists and xanthine antagonists at brain A1 adenosine receptors.
Ukena D, Jacobson K, Padgett W, Ayala C, Shamim M, Kirk K
FEBS Lett. 1986; 209(1):122-8.
PMID: 3803571
PMC: 3469266.
DOI: 10.1016/0014-5793(86)81096-1.
A1- and A2-selective adenosine antagonists: in vivo characterization of cardiovascular effects.
Evoniuk G, Jacobson K, Shamim M, Daly J, Wurtman R
J Pharmacol Exp Ther. 1987; 242(3):882-7.
PMID: 3656117
PMC: 5534265.
Adenosine in heart and lung disease. Proceedings of the first Cardiothoracic Institute Workshop. 30 March 1988, London. Abstracts.
Postgrad Med J. 1988; 64(756):820-8.
PMID: 3255927
PMC: 2429005.
DOI: 10.1136/pgmj.64.756.820.